Molecular Partners AG (SWX:MOLN)
Switzerland
· Delayed Price · Currency is CHF 3.230
+0.005 (0.16%)
Apr 4, 2025, 11:32 AM CET
Molecular Partners AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 4.97 | 7.04 | 189.56 | 9.33 | 9.34 | Upgrade
|
| Other Revenue | - | - | 0.04 | 0.42 | - | Upgrade
|
| Revenue | 4.97 | 7.04 | 189.6 | 9.75 | 9.34 | Upgrade
|
| Revenue Growth (YoY) | -29.38% | -96.29% | 1843.82% | 4.39% | -54.16% | Upgrade
|
| Cost of Revenue | 47.5 | 47.84 | 49.9 | 54.96 | 56.08 | Upgrade
|
| Gross Profit | -42.53 | -40.81 | 139.71 | -45.21 | -46.73 | Upgrade
|
| Selling, General & Admin | 18.68 | 20.3 | 23.09 | 18.21 | 11.6 | Upgrade
|
| Operating Expenses | 18.68 | 20.3 | 23.09 | 18.21 | 11.6 | Upgrade
|
| Operating Income | -61.22 | -61.11 | 116.61 | -63.42 | -58.33 | Upgrade
|
| Interest Expense | -0.03 | -0.03 | -0.61 | -0.55 | -0.3 | Upgrade
|
| Interest & Investment Income | 3.38 | 4.28 | 1.14 | 0.1 | 0.37 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.83 | -5.11 | 0.72 | 0.09 | -4.51 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.02 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Pretax Income | -54.04 | -61.98 | 117.85 | -63.78 | -62.78 | Upgrade
|
| Income Tax Expense | 0 | - | - | 0 | -0.01 | Upgrade
|
| Net Income | -54.04 | -61.98 | 117.85 | -63.79 | -62.76 | Upgrade
|
| Net Income to Common | -54.04 | -61.98 | 117.85 | -63.79 | -62.76 | Upgrade
|
| Shares Outstanding (Basic) | 34 | 33 | 32 | 31 | 25 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 33 | 33 | 31 | 25 | Upgrade
|
| Shares Change (YoY) | 3.85% | -1.49% | 7.29% | 24.02% | 16.75% | Upgrade
|
| EPS (Basic) | -1.59 | -1.89 | 3.63 | -2.06 | -2.51 | Upgrade
|
| EPS (Diluted) | -1.59 | -1.89 | 3.54 | -2.06 | -2.51 | Upgrade
|
| Free Cash Flow | -59.95 | -59.58 | 117.39 | -91.89 | -30.43 | Upgrade
|
| Free Cash Flow Per Share | -1.76 | -1.82 | 3.53 | -2.96 | -1.22 | Upgrade
|
| Gross Margin | - | - | 73.68% | - | - | Upgrade
|
| Operating Margin | -1231.73% | -868.26% | 61.50% | -650.17% | -624.21% | Upgrade
|
| Profit Margin | -1087.38% | -880.71% | 62.16% | -653.94% | -671.70% | Upgrade
|
| Free Cash Flow Margin | -1206.30% | -846.55% | 61.91% | -942.03% | -325.71% | Upgrade
|
| EBITDA | -60.23 | -60.18 | 119 | -60.85 | -55.44 | Upgrade
|
| EBITDA Margin | - | - | 62.76% | - | - | Upgrade
|
| D&A For EBITDA | 0.99 | 0.93 | 2.39 | 2.57 | 2.89 | Upgrade
|
| EBIT | -61.22 | -61.11 | 116.61 | -63.42 | -58.33 | Upgrade
|
| EBIT Margin | - | - | 61.50% | - | - | Upgrade
|
| Revenue as Reported | 4.97 | 7.04 | 189.6 | 9.75 | 9.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.